|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-7-10
|
|
pubmed:abstractText |
Functional iron deficiency is one reason for lack of response to erythropoietin treatment. Concomitant intravenous (IV) iron supplementation has the potential to improve response to erythropoietin, allowing a decrease in erythropoietin dose requirements. In a recent study of anaemic, iron-replete patients with lymphoproliferative malignancies (Leukemia, 21, 2007, 627), the haemoglobin (Hb) increase and response rate were significantly greater in patients receiving epoetin beta with concomitant IV iron compared with patients receiving epoetin beta without IV iron (P < 0.05). The present analysis aimed to investigate whether a combination of epoetin beta and IV iron is cost-effective compared with epoetin beta without IV iron.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1365-2710
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
365-74
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18613854-Aged,
pubmed-meshheading:18613854-Aged, 80 and over,
pubmed-meshheading:18613854-Anemia,
pubmed-meshheading:18613854-Cost-Benefit Analysis,
pubmed-meshheading:18613854-Dose-Response Relationship, Drug,
pubmed-meshheading:18613854-Drug Costs,
pubmed-meshheading:18613854-Drug Therapy, Combination,
pubmed-meshheading:18613854-Erythropoietin,
pubmed-meshheading:18613854-Female,
pubmed-meshheading:18613854-Hemoglobins,
pubmed-meshheading:18613854-Humans,
pubmed-meshheading:18613854-Injections, Intravenous,
pubmed-meshheading:18613854-Iron Compounds,
pubmed-meshheading:18613854-Lymphoproliferative Disorders,
pubmed-meshheading:18613854-Male,
pubmed-meshheading:18613854-Middle Aged,
pubmed-meshheading:18613854-Neoplasms,
pubmed-meshheading:18613854-Recombinant Proteins,
pubmed-meshheading:18613854-Sweden
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy.
|
|
pubmed:affiliation |
Department of Internal Medicine, Sundsvall Hospital, Sundsvall, Sweden. michael.hedenus@lvn.se
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
